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ABSTRACT. A 54-year-old woman with short bowel syn-
drome was supported with home parenteral nutrition. Six
months after receiving 2200 kcal/day of balanced home par-
enteral nutrition without biotin, she developed biotin deficiency
with complete hair loss, eczematous dermatitis, waxy pallor,
lethargy, and hypersthesias. Blood and urine samples were
collected prior to treatment. Serum zinc was 64 &mu;g/dl (nl 50-
150 &mu;g/dl), and the triene/tetraene ratio was 0.068 (nl 0.4),
thereby ruling out zinc and essential fatty acid deficiencies.
Serum biotin was 332 pg/ml (nl 520 &plusmn; 220 pg/ml), and urine
biotin was 5.22 ng/mg of creatinine (nl 4.3-95 with a mean of
30.2 ng/mg creatinine). The same parenteral nutrition regimen
was contained and oral biotin was administered (10 mg/day).
After 3 wk, serum and urine biotin levels were 650 pg/ml and
35.6 ng/mg creatinine, respectively. New hair growth was evi-
dent and all of her other symptoms resolved. Intravenous biotin
was then provided (5 mg/day) for a month after which serum
and urine biotin levels were 1316 pg/ml and 178 ng/mg creati-
nine, respectively. The patient has been subsequently main-
tained on an intravenous multivitamin product containing 60
&mu;g biotin per daily dose and remains free of signs and symptoms
of biotin deficiency. (Journal of Parenteral and Enteral Nutri-
tion 8:311-314, 1984)
Biotin deficiency was first recognized in animals and
later in man when fed raw egg white which contains
avidin, a glycoprotein which forms an insoluble complex
with biotin.’ This deficiency was successfully reversed
by dietary supplementation with biotin. Recently biotin-
responsive multiple carboxylase deficiencies have been
described in pediatric patients. 2,1 In addition, four case
reports have described biotin deficiency in patients sup-
ported with long-term total parenteral nutrition.4-7 The
present report documents a nutritional biotin deficiency
in an adult with short gut syndrome after biotin-free
parenteral nutrition for 1 yr.
CASE REPORT
A 54-yr-old married housewife was admitted to the
University of Michigan Hospitals in January 1980 with
acute mesenteric ischemia. Despite attempted mesen-
teric revascularization with an iliac-hepatic saphenous
vein bypass graft, she required resection of the right
colon, entire ileum, and all but the proximal 21 cm of
jejunum. The jejunum was anastomosed to the mid trans-
verse colon and she was discharged maintaining her
weight on an oral diet. In August 1980, she was readmit-
ted for correction of dehydration and malnutrition. In-
travenous hydration and various diet regimens were at-
tempted, but the patient continued to have watery stools,
weight loss, and poor nutrition. Total parenteral nutri-
tion (TPN) was initiated 10 days after admission for a
period of 4 wk. During this period, she increased her
weight from 36.8 to 48 kg. Weight maintenance on an
oral diet was attempted again for 6 wk, but was unsuc-
cessful. She reportedly had no raw egg white intake
during this period. Her weight dropped to 37 kg, and
TPN was reinstituted. After 6 more wk of hospitalization
and several unsuccessful attempts at weaning to an oral
diet, a Broviac catheter was placed and training for home
TPN was initiated. The patient was discharged home 2
wk later on 2 liter/day of 4.25% amino acids and 25%
dextrose. Five hundred ml of fat emulsion 10% (Intra-
lipid, Cutter Laboratories, Berkeley, CA) was given twice
a week. Other medications included propranolol 20 mg
(Ayerst Laboratories, New York, NY) twice a day and
hydrochlorothiazide 50 mg daily. The TPN solution con-
tained the estimated daily requirements of electrolytes,
trace elements, and vitamins. Biotin was not included in
the vitamin supplementation commercially available at
that time. Although one multivitamin product containing
biotin may have been available in the market, the neces-
sity of including biotin in the parenteral nutrition regi-
men was not strongly established, nor was such a product
a hospital formulary item at that time. Zinc was increased
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from 4 to 8 mg/day for 1 wk because of a low serum zinc
value of 23 pg/dl (nl 50-150 ~g/dl). A repeated serum
zinc level 1 month later was 82 ,g/dl..
Eight months later, in April of 1981, the patient was
readmitted to the hospital with severe abdominal pain.
Arteriography demonstrated occlusion of the iliac-he-
patic saphenous vein bypass. A thoracic aorta-common
hepatic bypass was successfully performed. At the time
of admission, the patient reported unusual hair loss every
time she combed her hair. Serum zinc determination was
normal. Daily zinc supplementation was nevertheless
increased to 8 mg and continued for 6 wk after which it
was reduced to 4 mg/day. Ten percent fat emulsion
supplementation, 500 ml twice a week, was continued as
before.
Postoperatively and at home, the patient continued to
be lethargic, depressed, and anorexic despite restoration
FIG. 1. The patient with biotin deficiency.
>f her normal weight by TPN. She gradually became
itaxic and developed progressive alopecia (Fig. 1). This
was accompanied by eczematous dermatitis, waxy pallor,
and diffuse hyperesthesias (Table I). The patient became
progressively depressed. At that time, serum zinc, serum
essential fatty acid, and plasma biotin levels were deter-
mined. There was no evidence for metabolic acidosis.
Biotin deficiency was suspected and treatment with daily
oral doses of 10 mg of biotin in a hydroalcoholic solution
was started empirically and continued for 22 days. The
decision to use oral biotin was made because biotin
injections were not immediately available. Serum zinc
was normal at 64 ~g/dl, and the triene/tetraene ratio was
0.068 (normal less than 0.4) indicating that hair loss and
other symptomatology was not due to zinc or essential
fatty acid deficiencies. Low plasma and urine biotin
levels then confirmed biotin deficiency (Table II). After
5 days of therapy, new hair growth was evident, and all
of her other symptoms had improved.
Three weeks later, parenteral biotin, 5 mg daily, was
added to her parenteral nutrition solution for 4 wk, after
which oral supplements of 10 mg/day were reinstituted.
When high dose biotin was discontinued, the patient was
begun on MVI-12 (USV Laboratories, Tuchaho, NY) in
her parenteral nutrition solution supplying 60 ing of
biotin per day.
She successfully maintained her weight at the ideal
recommended level of 50 kg. Her hair was fully grown 6
months later (Fig. 2). She is currently active at home
and exercises frequently on her bicycle, participates in
social activities with her family and friends, and eats a
regular diet of approximately 600-800 kcal/day. This is
supplemented by 2000 kcal of parenteral nutrition 5 days
a week. She continues to do well.
TABLE I
Clinical signs and symptoms of biotin deficiency
TABLE II
Results’
° Plasma and urinary free biotin concentrations were determined by a competitive protein-binding assay using 3H-biotin, avidin, and
nitrocellulose filters.’ Zinc was determined by atomic absorption spectrophotometry. The fatty acid composition of plasma lipid was determined
by gas chromatography of the methyl esters formed with boron tri-fluoride and methanol (courtesy of A. N. Siakotos, Indiana University School
of Medicine).
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FIG. 2. The patient 6 months after treatment with biotin.
DISCUSSION
Biotin is a coenzyme for several carboxylation reac-
tions and plays an important role in C02 fixation. As a
cofactor for both pyruvate carboxylase and acetyl co-A
carboxylase, biotin plays an important role in both car-
bohydrate and fat metabolism.’ Biotin deficiency is rare
unless a patient is deprived of biotin in the diet, is fed
raw egg white which renders biotin unabsorbable from
the intestine due to the formation of an avidin-biotin
complex, or unless the patient has juvenile multiple
carboxylase deficiency.2,3 Although a recommended die-
tary allowance for biotin has not been established, the
conventional mixed American diet containing approxi-
mately 100-300 gg of biotin will meet the needs of
practically all healthy adults. Probably half of the dietary
biotin is absorbed from the small bowel and excreted by
the kidneys in the active form.l2 Although biotin is not
commercially available at the present time in a single
injectable form, we have prepared a parenteral form from
d-biotin in normal saline, autoclaved it, and demonstra-
ted that it retains its biologic activity and stability.
Hair loss, dermatitis, and depression have been de-
scribed in deficiency states of zinc,’ essential fatty
acids,l° biotin,I-7 and with certain drugs such as propran-
oloL 11 Hair loss was the first symptom noted by our
patient and was progressive over a 3-month period. De-
spite zinc supplementation of greater than daily main-
tenance doses for 6 wk, she became extremely depressed,
with eczematous dermatitis, waxy pallor, lethargy, and
hyperesthesias. Her hair loss was almost complete. The
patient’s description of her deterioration was quite strik-
ing. Her mood was much more labile, and she was fre-
quently &dquo;discombobulated.&dquo; She noted her memory be-
came very poor and her ability to perform daily functions
markedly deteriorated. She had previously compounded
and administered her own parenteral nutrition prescrip-
tion, but became unable to do this without her husband’s
assistance. She completely lost her appetite for the little
food she ate and she reported that everything tasted like
straw during this period of time.
Because we initially suspected zinc deficiency as a
cause for the patient’s early symptoms of hair loss and
dermatitis, zinc supplementation was increased from 3
to 8 mg/day emperically for 1 month with no clinical
effect, and serum zinc levels were normal (Table II). Soy
bean oil emulsion was infused twice a week in amounts
that provided at least 3.2% of the patient’s daily caloric
intake as linoleic acid. This made essential fatty acid
deficiency very unlikely, and a normal triene/tetraene
ratio was confirmed by direct measurement (Table II).
This left two possible etiologies for the patient’s signs
and symptoms: propranolol therapy and biotin defi-
ciency. Propranolol administration may occasionally
produce side effects, including fatigue, mental depres-
sion, erythematous rash, and reversible alopecia.&dquo; Since
the patient had been successfully maintained on this
drug for over 2 yr without untoward sequalae, propran-
olol seemed to be an unlikely etiology. Thus, a tentative
diagnosis of biotin deficiency was considered and supple-
mentation initiated. It was decided not to reverse this
biotin deficiency with any of the oral biotin tablets or
multivitamin products containing biotin available at that
time because of the patient’s short bowel. Although MVI-
12 had been recently introduced on the market at that
time, it contained only maintenance levels of biotin and
correcting a single vitamin deficiency with a multivi-
tamin preparation was not appropriate. Intravenous bio-
tin of 5 mg/25 ml normal saline (d-biotin by Sigma
Chemical Co., St. Louis, MO) was then prepared by our
Pharmacy Laboratory. Sterile-autoclaved biotin solution
was analyzed and found to retain its activity and stabil-
ity ; oral doses of 10 mg in a 15 ml 60% ethanol cherry-
flavored solution were also prepared for immediate use
until the intravenous products were tested for sterility
and analyzed for activity. Sixty percent ethanol was used
as the solubilizing agent because biotin is more soluble
in alcohol (80 mg/100 ml of 95% alcohol) than water (22
mg/100 ml), and we rationalized that a rapid absorption
of ethanol might enhance the rate of absorption for biotin
in this patient with short bowel syndrome. The same
parenteral nutrition regimen was maintained as before,
and propranolol administration was also continued, so
that the only change in the patient’s daily regimen was
the addition of biotin.
The patient reported a euphoric state upon the initial
administration of biotin, presumably because of the al-
cohol content. On the 5th day of treatment, she reported
general overall improvement in her clinical state includ-
ing improvement of her depression, hyperesthesias, and
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FIG. 3. Patient’s plasma and urine biotin
levels during biotin deficiency and during
the course of treatment with biotin.
lethargy. She noted the growth of new hair on her scalp
and elsewhere on her body and her hair had returned to
normal length 6 months later.
The patient’s initial serum and urinary biotin concen-
trations were in the low normal range (Fig. 3). Her
plasma concentration was 1 SD below the mean, and her
urinary biotin excretion was almost 2 SD below the
mean. The rapid response of her symptoms to biotin
therapy as well as the increase in both plasma and
urinary biotin concentrations makes biotin deficiency
the likely cause of her pallor, ataxia, and alopecia.
We speculate that this patient’s short bowel may have
contributed to the development of the biotin deficiency
as hypothesized by others.’ The short bowel may have
decreased transit time, thereby reducing the chance of
adequate absorption from the little food she ate. More-
over, we further speculate that the broad spectrum an-
tibiotics which this patient was on may have altered the
intestinal flora and therapy decreased biotin production
by micro-organisms.
Table II shows that intravenous administration of one-
half of the oral biotin dose gave higher levels in the
serum and urine compared to the oral regimen. Both
regimens, however, were at greater than maintenance
level, and probably one-half of the oral dose or one-tenth
of the intravenous dose would have effectively reversed
the symptoms of biotin deficiency. Therefore high doses,
such as those used in pediatric patients with biotin-
responsive multiple carboxylase deficiency, probably
need not be given to patients with a straight forward
dietary deficiency. During the past year, our patient has
been supplemented daily with 1 mg biotin orally and 60
jig intravenously. In January 1983, her plasma biotin was
411.9 pg/ml and urine biotin was 13.3 ng/mg of creati-
nine. Both values are in the low-normal range suggesting
that a daily biotin supplementation of 60 Ag intrave-
nously, as now provided in commercial multivatimin
preparations, may not be sufficient for all patients.
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